NT_1170x120_1-11-18

Deepak Sapra

CutisPharma, Dr. Reddy’s announce API agreements

CutisPharma, Dr. Reddy’s announce API agreements

WILMINGTON, Mass. — CutisPharma has entered into active pharmaceutical ingredient (API) supply and joint development pacts with Dr. Reddy’s Laboratories Ltd. CutisPharma, which focuses on products for the prescription compounding market,  said Tuesday that it aims to advance several programs in its research and development portfolio — including RM-02, RM-03 and RM-06 — toward Food